Precision Optics Corporation to Host Third Quarter Fiscal 2022 Conference Call on Monday, May 16, 2022 | News

GARDNER, Mass., May 9, 2022 /PRNewswire/ — Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) announced today that it has scheduled a conference call to discuss third quarter fiscal 2022 financial results on Monday, May 16, 2022to 5:00 p.m. ET.

The Company intends to release its financial results and file its 10-Q after market close on Monday, May 16, 2022followed by the conference call.

Conference call details

date and time: Monday, May 16, 2022to 5:00 p.m. ET

Call information: Interested parties may access the conference call by dialing (844) 735-3662 or (412) 317-5705.

Live webcast information: Interested parties may access the conference call via a live webcast, available at

Replay: A replay of the conference call will be available until May 23, 2022 at (877) 344-7529 or (412) 317-0088, replay passcode 5109011. A web replay will be available at

About Precision Optics Corporation

Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies for the healthcare and defense/aerospace industries by providing services ranging from new product concept to mass production. With its industry-leading in-house design, prototype, regulatory and manufacturing capabilities as well as the electronic imaging expertise of its Lighthouse Imaging division and global sourcing, inspection and production resources at high volume of its Ross Optical division, the company is able to design and manufacture next-generation product solutions to meet the most demanding customer requirements. In healthcare, Precision Optics enables next-generation medical device companies around the world to meet the growing demands of the surgical community for more improved and smaller imaging systems for minimally invasive surgery as well than 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. . In addition to these next-generation applications, Precision Optics has provided leading medical device companies with a wide variety of optical products for decades, including complex endocouplers and specialty endoscopes. The Company also relies on its technical competence in micro-optics to enable cutting-edge defense and aerospace applications that require the highest quality standards and optimization of size, weight and power. For more information, visit

About forward-looking statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions, or any other statements relating to the Company’s future business or events or conditions future. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by the Company’s management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or anticipated in the forward-looking statements due to many factors, including the risks discussed in the Company’s Annual Report on Form 10-K and in other documents that we file from time to time. time with the SEC. All forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this report, unless law requires it.

View original content to download multimedia: -may-16-2022-301542844.html

SOURCE Precision Optics Corporation

Michael P. Boser